StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
5
This month
2
This year
2
Publishing Date
2024 - 04 - 01
2
2022 - 12 - 02
1
2021 - 09 - 28
1
2021 - 09 - 02
1
Sector
Health technology
5
Tags
Alliances
9
Antibody
18
Application
17
Approval
41
Asco
7
Asia
8
Atopic dermatitis
9
Baricitinib
9
Biocapital
37
Business
8
Cancer
57
Car-t
11
Cel
9
Cell
11
Cell carcinoma
7
China
33
Chinese
25
Clinical-trials-phase-iii
12
Collaboration
19
Companies
24
Dermatitis
11
Designation
15
Disease
16
Drug
33
Earnings
21
Events
17
Expected
9
Fda
23
Financial
21
Financial results
13
Granted
7
Growth
34
Ibi351
9
Ibi362
12
Market
54
Medical
8
Meeting
16
N/a
279
New drug
9
Obesity
10
Pancreatic
7
People
10
Phase 1
14
Phase 2
19
Phase 3
23
Positive
15
Presentation
11
Report
13
Research
19
Results
72
Review
8
Study
37
T-cell
11
Therapeutics
20
Therapy
37
Treatment
77
Trial
28
Tumors
8
Tyvyt
9
Update
12
Entities
Eli lilly and company
2
Incyte corporation
5
Symbols
ABBV
5
ABEO
7
ADCT
6
ADEA
14
ADXS
6
AGEN
6
ALPMF
17
ALPMY
17
ALVO
8
AQST
5
AZN
16
BGNE
10
BIIB
16
BLIN
5
BMY
12
BNTX
6
CEVA
5
CHRS
6
CPRX
5
CRCW
5
DTIL
5
DYAI
6
EXEL
9
FBIO
9
GILD
13
GMAB
14
GNMSF
11
GSK
10
HALO
6
IDCC
8
IGT
5
IMGN
6
INCY
5
JAGX
6
JAZZ
5
JNJ
45
KMDA
9
LCTX
5
LLY
26
MDT
7
MESO
5
MRK
9
NVO
5
NVS
10
NVSEF
6
OTLK
5
PFE
19
PNT
5
QTRHF
6
SGEN
10
SNY
34
SNYNF
19
SRNE
14
TAK
13
TEVJF
11
TGTX
6
TMDI
6
TNXP
7
VYGR
6
XNCR
6
Exchanges
Nasdaq
5
Nyse
2
Crawled Date
2024 - 04 - 01
2
2022 - 12 - 02
1
2021 - 09 - 28
1
2021 - 09 - 02
1
Crawled Time
00:00
2
12:30
1
15:00
1
17:00
1
Source
www.biospace.com
2
www.globenewswire.com
1
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
License
symbols :
INCY
save search
Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia
Published:
2024-04-01
(Crawled : 17:00)
- biospace.com/
INCY
|
$52.755
-0.12%
150K
|
Health Technology
|
-7.84%
|
O:
-0.6%
H:
0.0%
C:
-0.58%
license
collaboration
asia
agreement
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
Published:
2024-04-01
(Crawled : 12:30)
- globenewswire.com
INCY
|
$52.755
-0.12%
150K
|
Health Technology
|
-7.84%
|
O:
-0.6%
H:
0.0%
C:
-0.58%
license
collaboration
asia
agreement
china
Incyte and CMS Announce Collaboration and License Agreement for Ruxolitinib Cream in Greater China and Southeast Asia
Published:
2022-12-02
(Crawled : 15:00)
- biospace.com/
INCY
|
$52.755
-0.12%
150K
|
Health Technology
|
-34.53%
|
O:
-0.5%
H:
3.82%
C:
3.55%
collaboration
license
agreement
china
Innovent and UNION Therapeutics Enter into Strategic Collaboration and License Agreement for Orismilast, a Next-generation PDE4 Inhibitor for Inflammatory Dermatology Conditions
Published:
2021-09-28
(Crawled : 00:00)
- prnewswire.com
LLY
|
$745.04
-0.12%
410K
|
Health Technology
|
231.61%
|
O:
-0.0%
H:
0.0%
C:
-2.12%
INCY
|
$52.755
-0.12%
150K
|
Health Technology
|
-23.74%
|
O:
-0.27%
H:
0.81%
C:
-0.56%
collaboration
license
Innovent and GenFleet Announce Exclusive Global License Agreement for GFH925 (KRAS G12C Inhibitor)
Published:
2021-09-02
(Crawled : 00:00)
- prnewswire.com
LLY
|
$745.04
-0.12%
410K
|
Health Technology
|
191.67%
|
O:
0.0%
H:
0.9%
C:
0.84%
INCY
|
$52.755
-0.12%
150K
|
Health Technology
|
-31.43%
|
O:
0.23%
H:
0.65%
C:
0.03%
license
Gainers vs Losers
83%
17%
Top 10 Gainers
AGBA
|
News
|
$1.37
242.5%
76M
|
Finance
EGOX
|
$0.0835
131.94%
160M
|
ZCMD
|
$2.18
50.35%
24M
|
Commercial Services
CHRO
|
$1.73
41.22%
46K
|
n/a
RWOD
|
$10.61
32.68%
5.1M
|
n/a
NVFY
|
$2.77
31.28%
2.2M
|
Consumer Durables
AULT
|
$0.3174
31.1%
28M
|
Manufacturing
WISA
4
|
$7.11
20.71%
4.7M
|
Electronic Technology
MCB
4
|
$39.53
19.43%
88K
|
Finance
LIFW
|
News
|
$0.99
19.26%
800K
|
Administrative and Support and ...
Your saved searches
Save your searches and get alerts when important news are released.